Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Farrell to Lead Cepheid's International Operations; DNAe Names McCooke as CBO


Cepheid said this week that it has appointed Peter Farrell as executive vice president of international commercial operations.

He replaces Philippe Jacon, whom the company had named head of worldwide commercial operations in January. Jacon is transitioning to the role of president of Cepheid's High-Burden Developing Country business, replacing Paul Steuperaert, who is now focusing on the company's business in sub-Saharan Africa ahead of his 2015 retirement.

Farrell most recently served as divisional vice president and general manager at Abbott Laboratories. Prior to this, he held a number of sales and marketing positions in Abbott's Diagnostics division.

DNA Electronics this week announced the appointment of Nick McCooke as chief business officer.

McCooke has previously served as CEO of Solexa, which was acquired by Illumina in 2007. There, he led the development of Solexa's next-generation sequencing technology, which is the basis of Illumina's current product line, DNAe said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.